DECOY THERAPEUTICS INC

Watch

Share

DCOY·79400X602·US·Common Stock-13D/G

DCOY (DECOY THERAPEUTICS INC) is held by 2 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($29,004), UBS Group AG ($180). Net institutional sentiment: Mixed.

2

Holders

$29,184

Total Value

33% (3)

Consensus

1 buying - 2 selling

13F: Jun 30, 2026Insider & Congress: Updated regularly

Smart Money Verdict

View all

Loading verdict

Institutional (13F)50

Insider (Form 4)61

Activist (13D/13G)41

Congressional (STOCK Act)54

Holder Quality

16

★★★★★

Elite

30

★★★★

Strong

24

★★★

Solid

62

★★

Below

47

★

Weak

Held by 2 funds

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Sep 2, 2026 · Activists Aug 14, 2026 · Congress none

InsiderBTBurleson TessVest 2K shAug 31, 2026

InsiderGGGauthier Patricia G.Vest 2K shAug 31, 2026

InsiderLPLammers PaulVest 2K shAug 31, 2026

Checking access…

View all insider tradesView all activist filings

Top Holders

Top Holders (2)History

AllNewIncreasedHeldDecreasedExitedFirst report

Checking access…

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
VAVANGUARD CAPITAL MANAGEMENT LLC	New	4,034	$29,004	0.0%	-80.11%	30
UBS Group AG	Decreased	25(-95.4%)	$180	0.0%	+113.88%	0
MORGAN STANLEY	Exited	0(-100.0%)	$7	0.0%	+989.39%	0

DCOYDECOY THERAPEUTICS INC

1M3M6M1Y3Y5Y

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer